The association between the Th-17 immune response and pulmonary complications in a trauma ICU population

Cytokine

Volumn 76, Issue 2, 2015, Pages 328-333

  Holloway, Travis L ^a   Rani, Meenakshi ^a   Cap, Andrew P ^b   Stewart, Ronald M ^a   Schwacha, Martin G ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; IL 17; Inflammation; Injury

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTELEUKIN 17A; INTELEUKIN 17F; INTELEUKIN 22; INTELEUKIN 23; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BLOOD; BLOOD TRANSFUSION; BRONCHOSCOPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INTENSIVE CARE UNIT; LUNG DISEASE; LUNG LAVAGE; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; TH17 CELL; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; COMPLICATION; IMMUNOLOGY; INJURY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; TH17 CELLS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84943819492     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.09.003     Document Type: Article

References (31)

1. Calfee C.S., Eisner M.D., Ware L.B., Thompson B.T., Parsons P.E., Wheeler A.P., et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit. Care Med. 2007, 35:2243-2250.
2. Shere-Wolfe R.F., Galvagno S.M., Grissom T.E. Critical care considerations in the management of the trauma patient following initial resuscitation. Scand. J. Trauma Resusc. Emerg. Med. 2012, 20:68.
3. Ang D.N., Rivara F.P., Nathens A., Jurkovich G.J., Maier R.V., Wang J., et al. Complication rates among trauma centers. J. Am. Coll. Surg. 2009, 209:595-602.
4. Trouillet J.L., Chastre J., Vuagnat A., Joly-Guillou M.L., Combaux D., Dombret M.C., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 1998, 157:531-539.
5. Dancey D.R., Hayes J., Gomez M., Schouten D., Fish J., Peters W., et al. ARDS in patients with thermal injury. Intensive Care Med. 1999, 25:1231-1236.
6. Erickson S.E., Martin G.S., Davis J.L., Matthay M.A., Eisner M.D. Recent trends in acute lung injury mortality: 1996-2005. Crit. Care Med. 2009, 37:1574-1579.
7. Hudson L.D., Milberg J.A., Anardi D., Maunder R.J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 151:293-301.
8. Tanaka S., Yoshimoto T., Naka T., Nakae S., Iwakura Y., Cua D., et al. Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J. Immunol. 2009, 183:7523-7530.
9. Wilson R.H., Whitehead G.S., Nakano H., Free M.E., Kolls J.K., Cook D.N. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2009, 180:720-730.
10. You Q.H., Zhang D., Niu C.C., Zhu Z.M., Wang N., Yue Y., et al. Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone. Cytokine 2014, 66:78-86.
11. Nembrini C., Marsland B.J., Kopf M. IL-17-producing T cells in lung immunity and inflammation. J. Allergy Clin. Immunol. 2009, 123:986-994.
12. Gu C., Wu L., Li X. IL-17 family: cytokines, receptors and signaling. Cytokine 2013, 64:477-485.
13. Oppeltz R.F., Rani M., Zhang Q., Schwacha M.G. Burn-induced alterations in toll-like receptor-mediated responses by bronchoalveolar lavage cells. Cytokine 2011, 55:396-401.
14. Schwacha M.G. Gammadelta T-cells: potential regulators of the post-burn inflammatory response. Burns 2009, 35:318-326.
15. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., O'Brien R.L. Gammadelta T cells: an important source of IL-17. Curr. Opin. Immunol. 2008, 20:353-357.
16. Hellewell S.C., Morganti-Kossmann M.C. Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury. Mediators Inflamm. 2012, 2012:356494.
17. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012, 307:2526-2533.
18. Walkey A.J., Summer R., Ho V., Alkana P. Acute respiratory distress syndrome: epidemiology and management approaches. Clin. Epidemiol. 2012, 4:159-169.
19. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353:1685-1693.
20. Brun-Buisson C., Minelli C., Bertolini G., Brazzi L., Pimentel J., Lewandowski K., et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004, 30:51-61.
21. Kramer A.A., Zimmerman J.E. A predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stay. BMC Med. Inform. Decis. Mak. 2010, 10:27.
22. Treggiari M.M., Hudson L.D., Martin D.P., Weiss N.S., Caldwell E., Rubenfeld G. Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit. Care Med. 2004, 32:327-331.
23. Fouser L.A., Wright J.F., Dunussi-Joannopoulos K., Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol. Rev. 2008, 226:87-102.
24. Miossec P., Kolls J.K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 2012, 11:763-776.
25. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
26. Flierl M.A., Rittirsch D., Gao H., Hoesel L.M., Nadeau B.A., Day D.E., et al. Adverse functions of IL-17A in experimental sepsis. FASEB J. 2008, 22:2198-2205.
27. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 2006, 6:329-333.
28. Yiu H.H., Graham A.L., Stengel R.F. Dynamics of a cytokine storm. PLoS ONE 2012, 7:e45027.
29. McTiernan C.F., Lemster B.H., Frye C., Brooks S., Combes A., Feldman A.M. Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ. Res. 1997, 81:493-503.
30. Agrawal A., Zhuo H., Brady S., Levitt J., Steingrub J., Siegel M.D., et al. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303:L634-L639.
31. Parsons P.E., Eisner M.D., Thompson B.T., Matthay M.A., Ancukiewicz M., Bernard G.R., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 2005, 33:1-6.